ARTICLE | Clinical News
ABX-A regulatory update
May 19, 2014 7:00 AM UTC
Abeona said FDA granted Orphan Drug designation to ABX-A to treat mucopolysaccharidosis IIIA (MPS IIIA, Sanfilippo A syndrome) and to ABX-B to treat mucopolysaccharidosis IIIB (MPS IIIB, Sanfilippo B...